These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9179261)

  • 41. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.
    Nazeer T; Malfetano JH; Rosano TG; Ross JS
    Am J Clin Pathol; 1992 Jun; 97(6):764-9. PubMed ID: 1595596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cathepsins D, B, and L in malignant human lung tissue.
    Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
    Clin Cancer Res; 1996 Mar; 2(3):561-8. PubMed ID: 9816204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes].
    Wang Z; Zhao X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):164-6. PubMed ID: 11263354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
    Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
    Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cathepsin D activity in gastric cancer].
    Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
    Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer.
    Nadji M; Fresno M; Nassiri M; Conner G; Herrero A; Morales AR
    Hum Pathol; 1996 Sep; 27(9):890-5. PubMed ID: 8816882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer.
    Kandalaft PL; Chang KL; Ahn CW; Traweek ST; Mehta P; Battifora H
    Cancer; 1993 May; 71(9):2756-63. PubMed ID: 8385566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung].
    Xu Y; Zhou XJ; Dong YC; Ma HH; Lu ZF; He Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):451-5. PubMed ID: 19781191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
    Kojima H; Shijubo N; Abe S
    Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
    Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
    Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
    Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
    J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
    Cui Y; Liu J; Yin HB; Liu YF; Liu JH
    Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The immunohistochemical expression of cathepsin D in colorectal cancer.
    Valentini AM; Pirrelli M; Armentano R; Caruso ML
    Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of cathepsin D in transitional cell bladder tumours.
    Lipponen PK
    J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
    Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
    Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical localization of cathepsin D in colorectal tumors.
    Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
    Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.
    Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T
    Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
    Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
    Inoue T; Ishida T; Sugio K; Sugimachi K
    Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.